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Mice of the CBA/N strain exhibit X-linked immunodeficiency (xid) affecting 
B  lymphocytes (1).  B cells in xid mice are substantially reduced in number and 
lack the mature  Lyb-5  ÷ late-appearing subset of B  cells found in normal mice 
(1). Xid B cells are viewed as immature B cells, although whether these cells are 
the exact counterpart of the early B cells found in normal mice is still unclear. 
Recently, two groups (2,  3) reported that xid nu nu mice contain far fewer B 
cells than euthymic xid mice. This finding suggests that the thymus might play a 
role in the differentiation of xid  B cells. Since the defect in the nude mouse is 
pleiomorphic, however, the above studies could not exclude the possibility that 
factors other  than  the  absence  of the  thymus caused  the  reduction  in  B  cell 
numbers. In this respect, one would like to know: (a) Does surgical thymectomy 
lead to the B cell defect seen in xid nu nu mice? (b) If so, does the defect reflect 
an influence of mature T  cells rather than thymic humoral factors? This paper 
addresses these questions. 
Materials and Methods 
Mice.  (C57B6/6 [B6] x  CBA/J)F~, (B6 x  DBA/2)F1, and CBA/Ca mice were obtained 
from The Jackson Laboratories, Bar Harbor,  ME. CBA]N and (CBA]N  x  DBA]2)FI 
mice were kindly provided by Dr. D. Mosier, Institute for Cancer Research, Philadelphia, 
PA. Male mice were used in all experiments. 
Thymectomy.  Mice aged 6-8 wk were thymectomized by the method of Miller (4) and 
were left for 4-6 wk before irradiation and marrow reconstitution. 
Preparation of Chimeras.  Mice were irradiated and reconstituted with anti-Thy-l.2 and 
complement (C')-treated marrow as described previously (5). Chimeras were maintained 
on neomycin and polymyxin B in the drinking water for 3-5 wk postreconstitution (5) 
and housed in a positive pressure isolation unit. 
Irradiation.  Mice were exposed to t37Cs 3, irradiation using a Gamma cell irradiator 
(Atomic Energy of Canada Ltd., Ottawa, Canada) at a dose rate of 92 rad/min. 
Antibodies Used for Cytotoxicity Assays.  The following antibodies were used: monoclonal 
anti-Thy-l.2 (JIj) antibody (6) (ascites fluid diluted to 1:20); affinity-purified rabbit anti- 
mouse IgG (RaMIg) antiserum obtained from Cappel  Laboratories, Cochranviile, PA; 
monoclonal antibody  J 11 d (6) (culture supernatant diluted 1:5); monoclonal anti-I-A  k (11- 
5.2) antibody (ascites fluid diluted to 1:10) from hybridoma cells kindly provided by the 
Herzenberg group, Stanford University; and monoclonal anti-KbD  b (28-8-6S)  antibody 
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(culture supernatant diluted to 1:5), cells obtained through the courtesy of Dr. K. Ozato 
and Dr. D. H. Sachs from the American Type Culture Collection, Rockville, MD. RaMIg 
was used at a final concentration of 1:20. This antiserum is heavy and light chain specific 
and has a titer of >1:200 on normal spleen and lymph node (LN) B cells; the antibody is 
negative for purified T cells and lyses >95% of Thy-1- cells in LN and >80% of Thy-1- 
spleen cells (indistinguishable from the numbers of cells stained with fluoroscein-labeled 
RaMIg). The J1 ld antibody lyses >95% ofIg  + cells in spleen and LN and also reacts with 
a proportion of"null" cells in spleen and marrow; the antibody does not react with mature 
T cells. 
Cytotoxicity Assays.  A one-step assay was used, using Ficoll gradient-separated cells (6). 
A  mixture of mouse spleen-absorbed guinea pig serum (final  concentration,  1:6)  and 
rabbit serum (final concentration,  1:60)  was used as a  source of C'.  Cell viability  was 
measured by phase contrast microscopy. 
Thoracic Duct Cannulation.  Thoracic duct lymphocytes (TDL) were collected as de- 
scribed elsewhere (7). 
Results 
The simplest approach  for studying the effects of thymectomy on xid B  cell 
differentiation would be to examine the effects of neonatal thymectomy. This 
approach  has two drawbacks.  First, some T  cells exit from the thymus before 
birth  (8).  Second,  the  "runting"  syndrome  that  often  develops  in  neonatally 
thymectomized mice can cause a  sudden and unpredictable disappearance of B 
cells, presumably as the result of infection (7). The use of adult thymectomized, 
irradiated marrow-reconstituted mice largely avoids these two problems. 
The approach we adopted was to transfer anti-Thy-1 plus C'-treated CBA/N 
(xid +) vs.  CBA/Ca (xid-)  marrow into adult  thymectomized (ATx),  irradiated 
(1,050 rad) (B6 X CBA/J)F1 (xid-) mice. Sham thymectomized (STx) mice were 
used as a control. The degree of donor cell chimerism developing in the recipients 
was established with the aid of host-specific anti-H-2 antibody. Chimeras were 
examined at 7-10 wk postreconstitution. The chimeras used in the experiments 
shown in Tables I-III were all in conspicuously good health. 
B  Cells  in  Spleen,  LN,  and  TDL.  With  recipients  of nondefective CBA/Ca 
marrow, thymectomy had little or no effect on the total number of Ig  ÷ B cells in 
spleen,  LN, or TDL (Tables  I  and  II, groups A  vs. B).  Very different results 
were found with recipients of xid CBA/N marrow. The control STx recipients 
of CBA/N marrow showed a  three- to fourfold reduction of B  cells relative to 
recipients of CBA/Ca marrow (groups C vs. A); a similar reduction in total B cell 
numbers is seen in normal (nonchimeric) xid mice relative to xid- controls (1). I 
ATx  recipients of CBA/N  marrow  cells showed a  much more profound defi- 
ciency of B  cells.  This  deficiency  was  least  obvious  in  the  spleen,  although 
considerable variation was observed between one batch of chimeras and another. 
In the experiment illustrated in Table I, total splenic Ig  + B cells were fivefold 
less in CBA/N ---* ATx F~ chimeras than in the STx controls. A less pronounced 
(two- to fourfold) reduction in splenic B cells was found in two other batches of 
chimeras. In a  further two batches,  however,  Ig  + cells were virtually absent in 
the spleen (Table I, footnote |). 
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TABLE  I 
Numbers ofT and B cells in Spleen and LN of Adult Thymectomized, Irradiated (B6 X CBA/J)F~ 
Mice Reconstituted 9 Wk Previously with CBA/N vs. CBA/Ca Marrow* 
Cytotoxic indices with:  Total number (x 10  -°) of: 
Cells transferred to irra-  Treat- 
Group  diated  (B6 × CBA/J)FI  ment of  Lymph-  Thy_l + 
mice  recipients  a-Thy-1,2  RaMIg  a-I-A  k  J1 ld  a-D  r  oid  cells  Ig  ÷ ceils 
cells 
Spleen 
A  CBA/Ca BM*  STx  27!  57  69  71  3  152  41.7  86.2 
(2)  (8)  (4)  (1)  (3)  (16)  (7)  (11) 
B  CBA/Ca BM  ATx  -2  82  91  90  0  109  <1.0  88,8 
(6)  (4)  (I)  (4)  (1)  (8)  (2) 
C  CBA/N BM  STx  44  39  40  48  6  80.3  37.2  29.6 
(11)  (10 l  (8)  (3)  (1)  (28)  .  (19)  (5) 
D  CBA/N BM  ATx  6  30 ~  48  57  3  21.1  1.3  6.1 
(6)  (12)  (6)  (6)  (2)  (5)  (0.3)  (4) 
E  CBA/N BM + 25 ×  l0  s  ATx  37  47  50  56  7  24.3  8.8  11.5 
CBA/N T cells'  (6)  (7)  (10)  (9)  (3)  (4)  (0.8)  (4) 
Lymph nodes 
A  CBA/Ca BM  STx  55  45  46  44  5  48.7  26.7  21.9 
(1)  (I)  (4)  (3)  (2)  (11)  (6)  (1 I) 
B  CBA/Ca BM  ATx  4  92  95  94  3  21.5  0.8  19.8 
(4)  (1)  (3)  (1)  (1)  (4)  (0.6)  (4) 
C  CBA/N BM  STx  84  17  18  19  5  39.5  33,2  6.7 
(1)  (5)  (1)  (2)  (6)  (7)  (5)  (1.3) 
D  CBA/N BM  ATx  42  28  45  49  37  0.9  0,4  0.3 
(0.3) 
E  CBA/N BM + 25 ×  l0  s  ATx  67  33  39  39  10  10.7  7.3  3.5 
CBA/N T cells'  (11)  (7)  (1 I)  (7)  (7)  (0.9)  (2)  (0.4) 
* Data based on individual counts in three to five mice per group. Mice were assayed over a 4-(i period and were all from 
the same batch.  Total cell counts refer to total  numbers of live plus dead cells. LN cells were pooled from axillary, 
inguinal, cervical, and mesenteric nodes. 
* Bone marrow (BM) cells were injected intravenously  in a dose of 5 × 106 viable cells after pretreatmem with monoclonal 
anti-Thy-l.2 antibody plus C'. 
e Arithmetic mean (SD) of data from three to five mice per group. In group D, the low LN cell yields required pooling 
the cells (from five donors) to measure cytotoxic  indices. All cell populations  were passed through Ficoll gradients to 
remove dead cells. Background lysis with cells treated with C' alone was usually <5%. 
I In another two batches of chimeras,  Ig  ÷ cells in group D were virtually absent from the spleen (0-5%) as assessed either 
by immunofluorescence  or by cytotoxicity. The spleen cells in these batches of mice were also Ia- (<  10%) and consisted 
mostly of large lymphoid cells; 50-70% of these cells were lysed by monoclonal J 1  l d antibody. 
T  cells were prepared from pooled LN of irradiated  (1,000 rad) (B6 x  CBA/J)F~ mice reconstituted 6 mo before with 
T  cell-depleted  CBA/N marrow cells. LN cells from the chimeras were first passed over nylon wool columns and then 
treated with a cocktail of RaMlg and anti-D b antibody plus C'. The surviving cells were >99.5% Thy-1 + and contained 
+  b  no detectable  lg  cells  or D -bearing (host) cells. T  cells were injected  intravenously  3 d after irradiation  and marrow 
reconstitution. 
LN and  TDL of ATx recipients of CBA/N marrow were virtually acellular, 
and numbers of B cells were reduced by 20-25-fold relative to the STx controls 
(Tables I and II, groups C vs. D). This striking deficiency of B cells was a constant 
finding seen in five separate batches of chimeras (TDL were examined in only 
two batches).  Interestingly,  a  high  proportion  (35-70%) of the  LN and  TDL 
from CBA/N ~  ATx  FI chimeras were Thy-1 ÷ cells. Most of these cells could 
be lysed with anti-D b antibody plus C', and thus were presumably radioresistant 
T  cells of host origin;  in absolute terms,  these cells were very few in number, 
i.e., <106 cells per mouse. 
Influence of Mature T  Cells.  Group E  of Tables I and II shows the effect of 
adding mature CBA/N T  cells to CBA/N --~ ATx FI chimeras.  The injected T 
cells (>99.5 % Thy-1 +) were taken from L N of long-term CBA/N ~  F I chimeras, Group 
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TABLE  II 
Numbers ofT and B Cells in TDL of Adult Thyraectoraized, Irradiated (B6 X CBA/J)F~ Mice 
Reconstituted 8 Wk Previously with CBA/N vs. CBA/Ca Marrow* 
Cytotoxic indices on  I Total number (X 10 -s)  Cytotoxic indices on un-  TDL pretreated with 
Cells transferred to irradi-  treated TDL  RaMIg +  C'*  of: 
ated (B6 X CBA/J)FI mice 
a-Thy-l.2  RaMIg a-D  b  a-Thy-l.2  RaMIg a-D  b 
Treat- 
ment of 
recipients 
CBA/Ca BM  STx  63  36  0  1 
(10)  (5)  (1) 
CBA/Ca BM  ATx  5  93  6 
(4)  (3)  (6) 
CBA/N BM  STx  84  16  9 
(5)  (3)  (4) 
CBA/N BM  ATx  64  35  58 
(2)  (3)  (4) 
CBA/N BM +  25 x  10 n  ATx  65  38  16 
CBA/N T  cells  (2)  (9)  (4) I 
--  D  m 
99  2  4 I 
96  2  85 I 
98  0  201 
TDL  Thy'I+  Ig+ 
cells  cells ! 
42.2  26.2  15.1 
(8)  (05! 
14.9  8  13.9 
(2)  (0.5)  (2) 
28.8  24.3  4.7 
(6)  (5)  (1) 
O.7  O.5  O.2 
(0.3)  (0.3)  (0.1) 
6.5  4.3  2.4 
(2)  (2)  (0.2) 
* As for Table I. Mice were from the same batch as assayed in Table 1; three to five mice per group. TDL were collected 
from 0 to 24 h postcannulation. BM, bone marrow. 
* Aliquots of pooled TDL were treated  with RaMlg plus C' and then depleted of dead cells. 
! p  values: group A vs. B, >0.05; A vs. C, <0.01; C vs. D, <0.01 ; D vs. E, <0.01. 
! When other aliquots of TDL were pretreated with a-Thy-1 antibody plus C' to yield purified B cells, <5% of these cells 
were lysed with a-D  b +  C'. 
thereby ensuring tolerance to host alloantigens (see Table I, footnote s). The T 
cells were injected in a dose of 25  x  106 per mouse 3 d after marrow reconsti- 
tution. This injection restored the T  cell pool to only ~20% of normal (Tables I 
and II, groups C vs. E).  Significantly,  however, the injection of T  cells substan- 
tially abrogated the deficiency of B cells, particularly in LN and TDL.  B cells in 
these tissues were only twofold less than in the CBA/N --> STx F~ controls. 
Differentiation  of xid B  Cells in Totally H-2-different  Chimeras.  The capacity of 
T  cells to promote xid B cell differentiation might reflect direct H-2-restricted 
T-B interaction during ontogeny. If so, T  cells differentiating in a thymus lacking 
the H-2 determinants expressed on the B cells would be expected to lose the 
capacity to help the differentiation of these B cells. Table III presents evidence 
against this notion. The table shows the number of B cells developing in irradiated 
(1,000  rad)  (B6  x  DBA/2)F1  (bxd)  mice reconstituted with xid  marrow cells 
taken  either  from  (a)  totally  H-2-different  CBA/N  mice  (k  ~  bxd)  or  (b) 
semisyngeneic (CBA/N X DBA/2)F] male mice (kxd ~  bxd). The numbers of B 
cells developing in the spleens of the two groups of recipients were very similar. 
It should be mentioned that T  cells taken from the totally H-2-different CBA/N 
(B6  ×  DBA/2)FI  chimeras  were  markedly  defective  in  providing  sheep 
erythrocyte-specific T  helper function for H-2-compatible CBA/Ca B cells, i.e., 
B cells expressing nonthymic H-2 determinants (data not shown). 
Discussion 
The data in this paper on thymectomized, irradiated, marrow-protected mice 
extend the earlier studies on xid nu nu mice (2, 3) and provide direct evidence 
that the differentiation of xid B cells is thymus-dependent, at least in part. The 
fact that  addition  of purified  LN  T  cells largely overcame the  B  cell  deficit 
suggests that mature T  cells rather than thymic humoral factors control xid  B 
cell development. 
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TABLE  III 
Differentiation  of CBA/N B Cells in Spleens of Totally H-2-different  vs. Semisyngeneic Bone Marrow 
Chimeras* 
Time  Cytotoxic indices with:  Total number (X 10 4) 
after re-  No.  of: 
Marrow cells (male)  constitu-  of 
Irradiated hosts  used for reconstitution  tion  mice  a-Thy-l.2  RaMlg  a_H.2~,  Spleencells Thy'l+cells cellslg÷ 
(weeks) 
(B6 x  DBA/2)FI  CBA/Ca (k)  ]  8  3  421  30  6  105  47  32 
(bxd)  t  (19)  (1.0)  (2)  (17)  (13)  (10) 
11-13  2  43  44  1  163  72  70 
(11)  (6)  (1)  (6)  (6)  (20) 
(B6 x  DBA/2)F,  CBA/N (k)  ]  8  3  54  23  9  71  39  17 
(bxd)  t  (15)  (5)  (2)  (15)  (16)  (9) 
11-13  3  61  34  4  109  60  31 
(5)  (2)  (1)  (15)  (14)  (6) 
(B6 x  DBA/2)F~  (CBA/N x  DBA/2)FI  ]  8  3  45  31  5  63  29  20 
(bxd)  (kxd)  /  (10)  (11)  (1)  (18)  (4)  (10) 
11-13  6  42  28  5  72  33  21 
(5)  (9)  (2)  (19)  (4)  (7) 
* Adult (10 wk) (B6 x  DBA/2)FI mice were exposed to 1,000 rad and injected intravenously with 5 x  106 anti-Thy-l.2 + 
C'-treated bone marrow cells. 
* CBA/J anti-B6 antiserum absorbed with DBA/2 spleen. This antiserum lysed >90% of normal (B6 X DBA/2)F1 spleen 
cells. 
|  Mean of data (SD) derived from individual mice. 
and  TDL  B  cells.  Thus,  B  cells were virtually absent in  the  LN and  TDL  of 
CBA/N ---* ATx F] chimeras but reached nearly normal levels in the presence of 
mature T  cells. The findings in the spleen were less striking. Thus, whereas some 
batches of ATx chimeras  were almost devoid of Ig  + cells in the spleen,  others 
showed  only a  twofold  reduction.  These  findings  agree  closely with  the  two 
studies  in  xid  nu  nu  mice  (2,  3).  Although  the  LN  of xid  nu  nu  mice  were 
markedly depleted of B cells in both of these studies, gross depletion of splenic 
B cells was seen in only one study (2), and then only in two of three experiments. 
In the case of the two batches of our own chimeras that showed a total absence 
of Ig  + cells in the spleen, it is of interest that these mice looked less healthy than 
the other t~aree batches of chimeras (which were in excellent condition). For this 
reason,  we suspect that  the extreme depletion of xid B cells seen in the spleens 
of some mice might be an artifact reflecting B cell destruction as a consequence 
of infection (7). Thus, the T  dependency ofxid B cells might only apply to certain 
B cell subsets, e.g., to recirculating B cells prominent in LN and TDL; the young 
B cells entering the spleen from the marrow might be T  independent. 
Speculating on the significance of T-dependent xid B cell differentiation begs 
the question of whether xid B cells have an exact counterpart  in normal  mice. 
This issue remains unresolved. If normal mice did contain a component of cells 
resembling xid B cells, thymectomy (or congenital athymia) would be expected 
to  cause  a  significant  decrease  in  total  B  cell  numbers.  Although  no  such 
reduction  has  been  found,  either  in  spleen,  LN,  or  TDL  (Tables  I,  II  and 
reference  7),  the  possibility of a  small  (10%) reduction  is difficult to exclude. 
Moreover, compensatory overproduction of other B cells might hide the disap- 
pearance of a T-dependent subset. 
The alternative possibility is that xid B cells are a unique population that is not 
represented in normal  mice. We favor this view in light of recent experiments 
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marrow cells.  2 Unlike T  cells, the xid marrow-derived B cells developing in these 
double chimeras are  virtually undetectable by 6  mo postreconstitution.  These 
findings are difficult to reconcile with the view that xid B cells are the equivalent 
of the (sizeable) population of Lyb-5- immature B cells in normal mice. 
Why xid B cell differentiation should be T  dependent is difficult to envisage. 
The data in Table III make it unlikely that T  cells guide xid B cell differentiation 
via direct H-2-restricted cell interaction. The alternative possibility is that soluble 
T  cell  factors  control  xid  B  cell  differentiation.  One  might  test  this  idea by 
injecting ATx xid chimeras or xid nu nu mice with a  cocktail of T  cell factors, 
although careful studies on the requirement for inducing xid B cells to differen- 
tiate in vitro would probably be a more informative approach. 
Summary 
Evidence is presented that the in vivo differentiation of B cells expressing X- 
linked immunodeficiency (xid) is controlled by mature T  cells. Normal (C57BL/ 
6  ×  CBA/J)FI  mice were thymectomized (ATx),  heavily irradiated, and recon- 
stituted with  CBA/N  (xid)  or  CBA/Ca  (nondefective) marrow.  In contrast  to 
sham-operated  mice,  ATx  recipients  of xid  marrow  showed  an  almost  total 
absence of Ig  + B  cells in  lymph nodes (LN) and thoracic  duct lymph at 2  mo 
postreconstitution;  B  cells were  markedly reduced in the spleen  in some mice 
but only moderately in others.  Addition of mature T  cells soon after marrow 
reconstitution  substantially abrogated  the  B  cell  depletion.  In  control  experi- 
ments  with  nondefective  B  cells,  the  number  of B  cells  developing  in  ATx 
irradiated recipients of normal (xid-) marrow cells was not detectably lower than 
in sham-operated recipients. These data imply that a  subset of T-dependent B 
cells is either missing in normal mice or present in only very small numbers. 
Received for publication  13 February  1984. 
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